Medicine and Dentistry
Amputation
14%
Bleeding
20%
Cancer
23%
Chemoradiotherapy
14%
Colorectal Liver Metastasis
18%
Computer Assisted Tomography
14%
Conservative Treatment
15%
Desmoid Tumor
15%
Disease
45%
Drug Megadose
17%
Elderly Patient
18%
Familial Adenomatous Polyposis
14%
Granulocyte
19%
Hepatectomy
20%
Ileo-Anal Pouch
23%
Injury
47%
Intraductal Papillary Mucinous Tumor
15%
Ischemia
22%
Laparotomy
22%
Leukocyte
14%
Limb
25%
Limb Perfusion
39%
Lung Artery Pressure
15%
Lymph Node
19%
Lymph Node Metastasis
20%
Malignant Neoplasm
32%
Melphalan
28%
Metastatic Carcinoma
49%
Neoadjuvant Therapy
20%
Neoplasm
100%
Neutrophil
26%
Nodular Melanoma
45%
Obstruction
21%
Overall Survival
27%
Pancreas Adenocarcinoma
19%
Pancreas Cancer
15%
Pancreas Islet Cell Tumor
14%
Pancreaticoduodenectomy
17%
Postoperative Complication
29%
Proctocolectomy
18%
Rectum Cancer
27%
Recurrent Disease
36%
Soft Tissue Sarcoma
32%
Surgeon
21%
Surgery
75%
Surgical Anastomosis
17%
Surgical Approach
18%
Thromboxane
19%
Thromboxane B2
22%
Tumor Necrosis Factor
43%
Keyphrases
Amputation
17%
Chemotherapy
19%
Colorectal Cancer
21%
Colorectal Liver Metastases
19%
Desmoid Tumor
15%
Diapedesis
22%
Elderly Patients
19%
High Dose
17%
Ileal Pouch-anal Anastomosis
25%
Interleukin-2
14%
Intraductal Papillary mucinous Neoplasm
18%
Ischemia
43%
Isolated Limb Perfusion
36%
Israel
34%
Leukocytes
15%
Leukotriene B4 (LTB4)
33%
Liver
19%
Lung
41%
Lung Injury
27%
Lymph
30%
Lymph Node Metastasis
17%
Malignant Melanoma
26%
Mean Pulmonary Artery Pressure (mPAP)
16%
Medical Center
19%
Melanoma
18%
Melphalan
27%
Metastasis
23%
Metastatic Melanoma
15%
Neoadjuvant
16%
Neoadjuvant Therapy
18%
Neutrophils
26%
Overall Survival
21%
Oxygen Radicals
20%
Pancreatic Ductal Adenocarcinoma
17%
Pancreaticoduodenectomy
14%
Polymorphonuclear Leukocytes
21%
Postoperative Complications
24%
Reperfusion
35%
Resection
24%
Restorative Proctocolectomy
16%
Retroperitoneal Sarcoma
19%
Risk Factors
19%
Sham
17%
Soft Tissue Sarcoma
18%
Surgical Approach
19%
Thromboxane
38%
Thromboxane B2 (TXB2)
32%
Tumor
50%
Tumor Necrosis Factor-α
47%
Vascular Permeability
15%